Last reviewed · How we verify

Midazolam oral intake

Hospices Civils de Lyon · Phase 3 active Small molecule

Midazolam oral intake is a Benzodiazepine Small molecule drug developed by Hospices Civils de Lyon. It is currently in Phase 3 development for Procedural sedation and anxiolysis, Preoperative anxiety management, Acute anxiety disorders.

Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation and anxiolysis.

Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation and anxiolysis. Used for Procedural sedation and anxiolysis, Preoperative anxiety management, Acute anxiety disorders.

At a glance

Generic nameMidazolam oral intake
SponsorHospices Civils de Lyon
Drug classBenzodiazepine
TargetGABA-A receptor
ModalitySmall molecule
Therapeutic areaPsychiatry/Neurology
PhasePhase 3

Mechanism of action

Midazolam binds to GABA-A receptors and potentiates the effect of the inhibitory neurotransmitter GABA, leading to increased chloride ion influx and neuronal hyperpolarization. This results in depression of central nervous system activity, producing sedative, anxiolytic, anticonvulsant, and muscle relaxant effects. The oral formulation provides systemic absorption for procedural sedation and anxiety management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Midazolam oral intake

What is Midazolam oral intake?

Midazolam oral intake is a Benzodiazepine drug developed by Hospices Civils de Lyon, indicated for Procedural sedation and anxiolysis, Preoperative anxiety management, Acute anxiety disorders.

How does Midazolam oral intake work?

Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation and anxiolysis.

What is Midazolam oral intake used for?

Midazolam oral intake is indicated for Procedural sedation and anxiolysis, Preoperative anxiety management, Acute anxiety disorders.

Who makes Midazolam oral intake?

Midazolam oral intake is developed by Hospices Civils de Lyon (see full Hospices Civils de Lyon pipeline at /company/hospices-civils-de-lyon).

What drug class is Midazolam oral intake in?

Midazolam oral intake belongs to the Benzodiazepine class. See all Benzodiazepine drugs at /class/benzodiazepine.

What development phase is Midazolam oral intake in?

Midazolam oral intake is in Phase 3.

What are the side effects of Midazolam oral intake?

Common side effects of Midazolam oral intake include Drowsiness/sedation, Dizziness, Headache, Respiratory depression, Paradoxical agitation.

What does Midazolam oral intake target?

Midazolam oral intake targets GABA-A receptor and is a Benzodiazepine.

Related